首页> 外文学位 >The Curative Potential of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Malignancies.

【24h】

The Curative Potential of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Malignancies.

机译：嵌合抗原受体T细胞疗法对B细胞恶性肿瘤的治疗潜力。

获取原文

获取原文并翻译 | 示例

页面导航

著录项
相似文献
相关主题

著录项

作者
Koduri, Megha Pallavi.;
展开▼
作者单位

Boston University.;

展开▼
授予单位 Boston University.;
学科 Medicine.;Biology.
学位 M.S.
年度 2017
页码 108 p.
总页数 108
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Chimeric antigen receptor T-cell therapy for the treatment of aggressive B-cell non-Hodgkin lymphomas: efficacy, toxicity, and comparative chimeric antigen receptor products [J] . Bradley D. Hunter, Michael Rogalski Caron A. Jacobson Expert opinion on biological therapy . 2019,第7a12期

机译：嵌合抗原受体T细胞疗法治疗侵袭性B细胞非霍奇金淋巴瘤：疗效，毒性和比较嵌合抗原受体产物
2. Chimeric antigen receptor (CAR) T-cell therapy as a treatment option for patients with B-cell lymphomas: perspectives on the therapeutic potential of Axicabtagene ciloleucel [J] . Andreas Viardot, Verena Wais, Elisa Sala, Cancer Management and Research . 2019,第4期

机译：嵌合抗原受体（轿车）T细胞疗法作为B细胞淋巴瘤患者的治疗选择：视角于轴突的腋生虫蛋白的治疗潜力
3. Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma [J] . Salem Dalia A., Maric Irina, Yuan Constance M., Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis . 2018,第期

机译：B细胞成熟抗原的定量，一种骨髓瘤新型嵌合抗原受体T细胞疗法的靶标
4. Main Issues and Current Strategies in Enhancing the Efficacy of Chimeric Antigen Receptor T-Cell Therapy among Tumor Treatments [C] . Zhengting He International Conference on Frontiers of Biological Sciences and Engineering . 2020

机译：提高嵌合抗原受体T细胞治疗肿瘤治疗疗效的主要问题及目前策略
5. Optimizing and Understanding Checkpoint Inhibition Therapy and Chimeric Antigen Receptor Therapy Against Breast Cancer [D] . Xu, Nuo. 2020

机译：优化和解检查点抑制治疗和嵌合抗原受体治疗乳腺癌
6. Chimeric antigen receptor (CAR) T-cell therapy as a treatment option for patients with B-cell lymphomas: perspectives on the therapeutic potential of Axicabtagene ciloleucel [O] . Andreas Viardot, Verena Wais, Elisa Sala, 2019

机译：嵌合抗原受体（CAR）T细胞疗法作为B细胞淋巴瘤患者的治疗选择：Axicabtagene ciloleucel的治疗潜力的观点
7. Urokinase Plasminogen Activator Receptor (uPAR) Targeted Therapy with Switchable Chimeric Antigen Receptor T-Cell (sCAR T-Cell) Potential as Pancreatic Cancer Immunotherapy Agent [O] . Tungki Pratama Umar, Muhammad Syahrul Ramadhan, Nindya Mahfuza 2020

机译：尿激酶纤溶酶原激活剂受体（UPAR）靶向治疗可切换嵌合抗原受体T细胞（瘢痕T细胞）作为胰腺癌免疫治疗剂

The Curative Potential of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Malignancies.

著录项

相似文献

相关主题

期刊订阅